首页 | 本学科首页   官方微博 | 高级检索  
   检索      


The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia
Authors:Zhang P
Institution:Department of Internal Medicine, The First Medical College of Harbin Medical University, Heilongjiang Province, China.
Abstract:Arsenic trioxide (As2O3) has been shown to be even more effective than all-trans retinoid (ATRA) in the treatment of acute promyelocytic leukemia (APL). The combination of induction of apoptosis, induction of differentiation and inhibiting the proliferation, and killing of APL cells could be the main cellular mechanisms of As2O3 in APL treatment. As2O3 may affect APL cells by disturbing the activities of some important intracorporal enzymes, regulating the related gene expression and arresting the progression of cell cycle.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号